US 10202376
Heterocyclic compound
granted A61PA61P25/00A61P29/00
Quick answer
US patent 10202376 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P25/00, A61P29/00